Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.122.028561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Simon Hsu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Kidney Research Institute, Department of Medicine University of Washington Seattle WA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Background
The ratio of 24,25‐dihydroxyvitamin D 3 /25‐hydroxyvitamin D 3 (vitamin D metabolite ratio [VDMR]) may reflect functional vitamin D activity. We examined associations of the VDMR, 25‐hydroxyvitamin D (25[OH]D), and 1,25‐dihydroxyvitamin D (1,25[OH] 2 D) with cardiovascular disease (CVD) in patients with chronic kidney disease. Methods and Results This study included longitudinal and cross‐sectional analyses of 1786 participants from the CRIC (Chronic Renal Insufficiency Cohort) Study. Serum 24,25‐dihydroxyvitamin D 3 , 25(OH)D, and 1,25(OH) 2 D were measured by liquid chromatography–tandem mass spectrometry 1 year after enrollment. The primary outcome was composite CVD (heart failure, myocardial infarction, stroke, and peripheral arterial disease). We used Cox regression with regression‐calibrated weights to test associations of the VDMR, 25(OH)D, and 1,25(OH) 2 D with incident CVD. We examined cross‐sectional associations of these metabolites with left ventricular mass index using linear regression. Analytic models adjusted for demographics, comorbidity, medications, estimated glomerular filtration rate, and proteinuria. The cohort was 42% non‐Hispanic White race and ethnicity, 42% non‐Hispanic Black race and ethnicity, and 12% Hispanic ethnicity. Mean age was 59 years, and 43% were women. Among 1066 participants without prevalent CVD, there were 298 composite first CVD events over a mean follow‐up of 8.6 years. Lower VDMR and 1,25(OH) 2 D were associated with incident CVD before, but not after, adjustment for estimated glomerular filtration rate and proteinuria (hazard ratio, 1.11 per 1 SD lower VDMR [95% CI, 0.95–1.31]). Only 25(OH)D was associated with left ventricular mass index after full covariate adjustment (0.6 g/m 2.7 per 10 ng/mL lower [95% CI, 0.0–1.3]).
Conclusions
Despite modest associations of 25(OH)D with left ventricular mass index, 25(OH)D, the VDMR, and 1,25(OH) 2 D were not associated with incident CVD in chronic kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Kidney Research Institute, Department of Medicine University of Washington Seattle WA.
- Division of Nephrology and Hypertension, Department of Medicine Loyola University of Chicago Maywood IL.
- Division of Pediatric Nephrology Department of Pediatrics, The Children's Hospital of Philadelphia Philadelphia PA.
- Department of Biostatistics, Epidemiology, and Informatics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA.
- Center for Clinical Epidemiology and Biostatistics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA.
- Division of Nephrology-Hypertension University of California, San Diego San Diego CA.
ORCID-Profile: Simon Hsu, Leila R Zelnick, Nisha Bansal, Julia Brown, Harold I Feldman, Andrew N Hoofnagle, Tamara Isakova, Benjamin Lidgard, Cassianne Robinson-Cohen, Myles Wolf, Ian H de Boer
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- NCRR NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Hsu, S., Zelnick, L. R., Bansal, N., Brown, J., Denburg, M., Feldman, H. I., Ginsberg, C., Hoofnagle, A. N., Isakova, T., Leonard, M. B., Lidgard, B., Robinson-Cohen, C., Wolf, M., Xie, D., Kestenbaum, B. R., de Boer, I. H., & CRIC Study Investigators * (2023). Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.028561
Vancouver
Hsu S, Zelnick LR, Bansal N, Brown J, Denburg M, Feldman HI, et al. Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.028561
BibTeX
@article{Hsu2023,
author = {Hsu, Simon and Zelnick, Leila R and Bansal, Nisha and Brown, Julia and Denburg, Michelle and Feldman, Harold I and Ginsberg, Charles and Hoofnagle, Andrew N and Isakova, Tamara and Leonard, Mary B and Lidgard, Benjamin and Robinson-Cohen, Cassianne and Wolf, Myles and Xie, Dawei and Kestenbaum, Bryan R and de Boer, Ian H and CRIC Study Investigators *, CRIC Study Investigators *},
title = {Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.122.028561}
}
EUVIMED